All posts by imreal

Unleashing the Benefits and Eliminating Bias, Upcoming Webinar Hosted by Xtalks


From improved study design to reducing bias in data collection, this approach has the potential to revolutionize the clinical trial process and bring clinical trials closer to discovering life-saving treatments for patients in need.

This webinar will explore the benefits of incorporating behavioral science into clinical trials. The featured speakers will focus on how this approach can lead to improved trial design, increased patient engagement and reduced bias in data collection and analysis.

By utilizing behavioral science principles, clinical trial teams can better understand and address the factors that influence patient behavior and decision-making. This results in more accurate data collection and a more representative sample, leading to a greater understanding of the true efficacy and safety of treatments being tested.

Additionally, the application of behavioral science in clinical trials can improve patient engagement and retention, leading to a more successful trial outcome.

Finally, the webinar will discuss the importance of reducing bias in clinical trials and how behavioral science can help achieve this goal. From improved study design to reducing bias in data collection, this approach has the potential to revolutionize the clinical trial process and bring clinical trials closer to discovering life-saving treatments for patients in need.

Join the speakers to learn more about the benefits of behavioral science in clinical trials and how attendees can use this approach to make a difference in their own research.

Attendees will walk away with the following key takeaways: What behavioral science is and its importance in the clinical trials industry; Strategies for improving patient engagement, retention and compliance in clinical trials; And the importance of reducing bias in clinical trials and how behavioral science can achieve this goal.

Join experts from Datacubed Health, Marie Onakomaiya, Chief Scientific Officer; and Kyle Hogan, President, for the live webinar on Tuesday, March 28, 2023, at 1pm EST (10am PST).

For more information, or to register for this event, visit Behavioral Science in Clinical Trials: Unleashing the Benefits and Eliminating Bias.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

One Young Man’s Quest to Realize His Dream of Helping Others Through Blood Donation


News Image

I was shocked that in the year 2023, an otherwise healthy individual was denied donating much-needed blood simply because he needed minimal assistance to get up on the donation bed

According to The Arc (1), people living with a disability face discrimination, segregation, and exclusion from education, employment, community living, and routine daily activities.

Fortunately, Matthew, a young adult living in Florida, isn’t one to put up with being excluded. Matthew turned 16 in February and had big plans to celebrate by giving blood for the first time. As a lifelong Tampa Bay Lightning fan and big-time Victor Hedman fan, Matthew hoped to encourage 77 others to join him in honor of his hockey hero, who wears the #77 jersey.

Unfortunately, when he arrived at the blood collection center in his community on his birthday along with 20-25 of his supporters and prospective donors, he was told people who couldn’t independently get up on the donor bed couldn’t donate because of a Food and Drug Administration (FDA) requirement. Matthew, who has cerebral palsy, uses a wheelchair and can assist in transfers but needs a little help to get there.

“I was discouraged and sad because I had waited for years for this moment. Everyone there knew I was in a wheelchair before I got there. It wasn’t nice for them to deny me saving lives when I was ready and able to donate my blood,” said Matthew.

Matthew, his mother, and his former teacher and IntellectAbility Inside Sales Representative, Grace Gould, knew this wasn’t right. “I was shocked that in the year 2023, an otherwise healthy individual was denied donating much-needed blood simply because he needed minimal assistance to get up on the donation bed,” said Grace. “What about the organization’s responsibility for complying with the ADA (Americans with Disabilities Act)?”

They researched blood donation regulations, sent emails and received confirmation from the FDA’s Office of Blood Research and Review (OBRR) that there are no federal rules about one’s ability to independently get on or off the blood donation bed. Armed with this information, they returned to the blood collection center, which reconsidered its previous decision and issued a policy clarification referred to as “Matthew’s Memo,” indicating people can be assisted by their own supporters onto the donation bed. And as soon as the mandatory waiting period after being rejected as a donor is up, Matthew plans to be there, front and center, to donate.

“We applaud Matthew, his parents, and his supporters for their perseverance. And we encourage others to advocate for people with disabilities. And, as we celebrate National Cerebral Palsy Month, we recognize and salute the countless direct supporters who work to advocate for and enhance the lives of people with disabilities every day,” said Dr. Craig Escudé, IntellectAbility President.

To learn more about Matthew, click here https://replacingrisk.com/matthews-memo-an-advocacy-success-story/

About IntellectAbility

IntellectAbility provides tools and training to agencies, governmental entities, and supporters of people with intellectual and developmental disabilities to foster early recognition and mitigation of health risks, thereby improving health and wellness. One such tool is the Health Risk Screening Tool (HRST), of which they are the sole developer, producer, and distributor. The web-based HRST is the most widely used and validated health risk screening instrument for people with intellectual and developmental disabilities. IntellectAbility also provides numerous health-related and person-centered service training for supporters of people with IDD. With an unrelenting focus, IntellectAbility works to fulfill its mission of improving health and quality of life for people with intellectual and developmental disabilities and other at-risk populations. For more information, visit http://www.ReplacingRisk.com.

Source:

1) The Arc. 2023. https://thearc.org/about-us/mission-values/

Share article on social media or email:

The Luna Prenatal Test for Isolation of Circulating Fetal Cells Early in Pregnancy, Upcoming Webinar Hosted by Xtalks


Various genetic abnormalities were detected by the Luna Prenatal Test over the course of the study, including common trisomies, rare autosomal trisomies, microdeletions, microduplications and confined placental mosaicism.

For decades, many groups around the world have pursued the isolation and genetic analysis of circulating fetal cells from maternal peripheral blood as an improved form of noninvasive prenatal testing. However, the exceeding rarity of these cells in the blood of pregnant women has proven a challenging obstacle in the establishment of a reliable test methodology.

Luna Genetics has overcome this challenge using a unique combination of robust immunostaining, microfluidic enrichment, automated microscopy and single cell isolation. The noninvasive prenatal testing method was validated with over 200 high-risk cases undergoing chorionic villus sampling (CVS) or amniocentesis, along with 158 low-risk cases not undergoing CVS or amniocentesis. The Luna Prenatal Test showed near-perfect concordance with the CVS and amniocentesis results, and the few discordant cases were consistent with current knowledge of confined placental mosaicism. Various genetic abnormalities were detected by the Luna Prenatal Test over the course of the study, including common trisomies, rare autosomal trisomies, microdeletions, microduplications and confined placental mosaicism.

Furthermore, the Luna Prenatal Test methodology has been successfully applied to the identification of recessive monogenic disorders. In collaboration with Juno Genetics, the Luna Prenatal Test isolated circulating fetal cells from a pregnancy at risk of Walker-Warburg Syndrome. The cells were shipped overnight to Juno Genetics for sequencing and haplotype-based analysis of the POMT1 gene. The fetus was determined to be an unaffected heterozygous carrier of the POMT1 c.2167dupG allele, with concordant CVS results reported 10 days later. This case study demonstrates proof-of-concept for the application of the Luna Prenatal Test in detecting monogenic disorders early in pregnancy.

Register today to learn about a breakthrough in the reliable isolation and successful analysis of circulating fetal cells for noninvasive prenatal testing early in pregnancy. The webinar will include the path taken to establish the Luna Prenatal Test methodology, data from key validation cases and the future trajectory of the test.

Disclaimer: Namocell products are for research use only; not for diagnostic purposes.

Join Mason Ouren, R&D Scientist, Luna Genetics, for the live webinar on Friday, March 17, 2023, at 2pm EDT (11am PDT).

For more information, or to register for this event, visit Noninvasive Prenatal Testing: The Luna Prenatal Test for Isolation of Circulating Fetal Cells Early in Pregnancy.

Registrants will be provided with on-demand access to the webinar recording after the event.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Nationally Recognized Leader Releases New Book about Following Christ-Like Leadership


News Image

“Taking the narrow path does not mean you are rigid and narrow-minded. It is the opposite of that,” Oostra said. “The book provides you a framework, a context, a lens for your life narrative that will allow you to have a broader, more inclusive vision for your life purpose.”

One day, RD (Randy) Oostra was working on several presentations at the same time. A business presentation that had stacks of papers piled high was near a stack of files for his Bible study group. The two piles teetered and fell together, not only creating a mess but also a metaphor for the life Oostra was trying to lead, that both business leadership and faith can be intertwined. That metaphor turned into an idea that led Oostra to write his debut book, “The Narrow Path to Expansive Vision: Essays on following the light of the greatest leader who ever lived: Jesus Christ”.

The book is a guide for religious and secular readers looking to learn about Christ-inspired leadership. Oostra wants his readers to find a practical approach that can positively shape their lives by taking a Christ-inspired leadership framework based on the Gospels and comparing it with some of the most influential secular writings on leadership over recent decades.

“Taking the narrow path does not mean you are rigid and narrow-minded. It is the opposite of that,” Oostra said. “The book provides you a framework, a context, a lens for your life narrative that will allow you to have a broader, more inclusive vision for your life purpose.”

In addition, Oostra tells the story of his childhood set in a rigorous Dutch reformation community, and how he navigated through the science-based world of healthcare, as well as his frustrations with Church leadership.

“It is my hope that, through my journey, this Christ-inspired leadership framework can be of benefit to anyone who is exploring their life purpose, whether as a Christian or non-Christian, or someone who doesn’t have strong faith or any faith at all,” Oostra said.

“The Narrow Path to Expansive Vision: Essays on following the light of the greatest leader who ever lived: Jesus Christ”

By: RD Oostra

ISBN: 9781664283244 (softcover); 9781664283251 (hardcover); 9781664283237 (electronic)

Available at WestBow Press, Amazon and Barnes & Noble

About the author

RD (Randy) Oostra, for the last 13 years was the CEO of a $7 billion health and well-being organization with more than 40,000 employees in 28 states. Oostra is regarded as one of the nation’s top leaders in health care and has been named to prestigious industry lists including Modern Healthcare’s 100 Most Influential People for five consecutive years, and Becker’s Healthcare’s 100 Great Leaders to Know in Healthcare. Oostra was recently honored with the Jefferson Award for Public Service and was the recipient of the Ohio Hospital Association’s Donald R. Newkirk Award for making a significant lifetime contribution to the healthcare industry. Randy has received national recognition for his company’s far-reaching initiatives to address socioeconomic factors that impact health and well-being, including programs addressing hunger, access to food, education, financial security, housing, and community and economic development. To learn more, please visit https://www.westbowpress.com/en/bookstore/bookdetails/843227-the-narrow-path-to-expansive-vision

General Inquiries:            

LAVIDGE – Phoenix                        

Taylor Moralez

tmoralez@lavidge.com

480-306-6597

Share article on social media or email:

The Eric Carle Museum of Picture Book Art Teams with EnChroma to Enhance Experience for Color Blind Visitors


Eric Carle, Illustration for The Grouchy Ladybug. Collection of Eric and Barbara Carle. © 1977 Penguin Random House LLC

The Very Hungry Caterpillar and other works by Eric Carle are some of the most iconic and colorful in children’s literature. Now, with The Eric Carle Museum, color blind visitors will be able to fully enjoy his and other artist’s picture book illustrations in vivid color -Erik Ritchie, CEO, EnChroma

EnChroma® glasses to enable guests with color vision deficiencies to see the vibrant, colorful collages of Eric Carle

The Eric Carle Museum of Picture Book Art is the first art museum in Massachusetts to offer eyewear by EnChroma to visitors with color vision deficiencies, or “color blindness.” Beginning March 1, guests with color vision deficiencies can borrow special EnChroma glasses from The Carle to experience the Museum’s picture book art in clear, vibrant color for the first time. Eight pairs of eyewear are available, including glasses for both children and adults, indoor and outdoor use, and pairs adapted to fit over eyeglasses, through the EnChroma Color Accessibility Program™.

“Eric Carle said his painted papers were like his palette. His collages began by painting tissue paper with bright, acrylic paints, creating colorful patterns across each paper. And by partnering with EnChroma we can now offer glasses to color blind guests so they can better view those vibrant colors and designs, not only in the colorful collages of Eric Carle and other works in our collection, but outside appreciating nature in Bobbie’s Meadow,” said Courtney Waring, director of education.

One in 12 men (8%) and one in 200 women (.5%) are color vision deficient, which affects an estimated 13 million in the United States and 350 million worldwide. While people with normal color vision see over one million shades of color, those with color vision deficiency only see an estimated 10% of hues and shades. As a result, colors can appear muted, indistinct, and difficult to discern.

Click here for images of Eric Carle’s artwork as it appears to the color blind.

“The Very Hungry Caterpillar, and other works by Eric Carle, are some of the most iconic and colorful in children’s literature,” said Erik Ritchie, CEO of EnChroma. “And now, with the help of The Eric Carle Museum of Picture Book Art, their color blind visitors will be able to fully enjoy his and other artist’s picture book illustrations in vivid color.”

Special optical filters in EnChroma glasses help color blind people perceive a wider range of colors and to see them more vividly and distinctly. A study by the University of California, Davis, and INSERM, the French National Institute for Health and Medical Research, demonstrated the effectiveness of EnChroma glasses. A separate recent study in the scientific publication Eye-Nature also highlights the benefits of the glasses.

EnChroma Color Accessibility Program™

EnChroma is the leading advocate for accessibility for those with color blindness. Nearly 200 public institutions—including libraries, schools, universities, national parks, gardens, tourism bureaus—participate to help color blind visitors more fully experience colors in art, nature, and overcome obstacles to learning. EnChroma donates a pair of glasses for every pair an organization purchases. EnChroma also provides materials for institutions to educate the public or teachers, students, and parents about color blindness and its effects. Organizations interested in joining the program can email accessiblity@enchroma.com.

More information can be found at enchroma.com. Additional media materials can be downloaded here. Photos of three color blind people trying the EnChroma glasses at the Eric Carle Museum on February 27 are available for media here.

About The Museum:

The Eric Carle Museum of Picture Book Art is the international champion for picture books. We collect, preserve, and exhibit original illustrations, encourage guests of all ages to read and create art, and foster an ever-growing audience passionate about children’s literature.

The late Eric and Barbara “Bobbie” Carle co-founded the Museum in November 2002. Eric Carle was the renowned author and illustrator of more than 70 books, including the 1969 classic The Very Hungry Caterpillar. Since opening, the 43,000-square foot facility has served nearly one million visitors. The Carle has 9,000 permanent collection illustrations. The Carle has three art galleries, an art studio, a theater, picture book and scholarly libraries, and educational programs for families, scholars, educators, and school children. Bobbie’s Meadow is an outdoor space that combines art and nature. Educational offerings include professional training for educators around the country and master’s degree programs in children’s literature with Simmons University. The Museum offers digital resources, including art activities, book recommendations, collections, exhibition videos, and workshops for online visitors. Learn more at http://www.carlemuseum.org and on Facebook, YouTube, Twitter, and Instagram @CarleMuseum.

About EnChroma:

Based in Berkeley, Calif., EnChroma produces leading-edge eyewear for color blindness and low vision, and other solutions for color vision, sold online and through Authorized Retailers worldwide. Invented in 2010, EnChroma’s patented eyewear for color blindness combines the latest in color perception, neuroscience and lens innovation to improve the lives of people with color vision deficiency around the world. EnChroma received an SBIR grant from the National Institutes of Health (NIH). It earned the 2016 Tibbetts Award from the U.S. Small Business Administration in recognition of the firm’s innovative impact on the human experience through technology, and the 2020 Innovation Award in Life Sciences from the Bay Area’s East Bay Economic Development Alliance. For more information call 510-497-0048 or visit enchroma.com.

Media Contacts:

The Eric Carle Museum of Picture Book Art

Sandy Soderberg

Marketing Manager

P: 413.559-6315

sandys@carlemuseum.org

EnChroma

Kent Streeb

Vice President of Communications and Partnerships

P: 530.908.9225

kent@enchroma.com

Share article on social media or email:

Clinical Research as a Care Option Organized by the Conference Forum Announces Keynote and Key Topics for the 7th Annual Meeting


“I am looking forward to the 2023 CRAACO event as it is so important to explore ‘how’ clinical research can work with community hospitals,” said Madeline Sparks Cresswell, MBA, Research Program Manager – OHSU Health, Clinical Research Services Office (CRSO), Oregon Health & Science University.

The Conference Forum announced the launch of the 7th annual CRAACO®: Clinical Research as a Care Option conference, with the 2023 keynote and key topics. The meeting will take place May 22-23, 2023 at the Sheraton Imperial Hotel Raleigh-Durham Airport at Research Triangle Park, in Raleigh-Durham, NC.

“Embedding clinical research in the care setting can lead to higher rates of clinical trial participation inside of a health system, better health outcomes, lower cost of care and more satisfied patients,” said Jennifer Byrne, Founder, Board Member and CEO, Javara.

The CRAACO 2023 keynote, Julie Freischlag, MD, will be speaking on the future of integrated health. Dr Freischlag is CEO of Atrium Health Wake Forest Baptist, Chief Academic Officer and Executive Vice President, Advocate Health, and Executive Vice President for Health Affairs, Wake Forest University.

“CRAACO is the only conference that examines how we can integrate care and research to give many more patients access to clinical research,” said Valerie Bowling, Executive Director, Conference Forum.

Featured sessions include:

  • Evaluating and Strategizing the Financial Economics of Clinical Care in the Research Setting
  • Enabling All Care Locations to be Research Locations
  • Strategies for Building a Successful Clinical Research Team in the Care Setting
  • How Merck Increased Minority Representation in its Clinical Research Staff
  • Applying Digital Innovation to Streamline Clinical Research in the Care Setting for the Improvement of the Patient Experience
  • How Sanofi is Partnering with Hospital Systems to Leverage EHRs for Patient Matching from Care to Research

“I am looking forward to the 2023 CRAACO event as it is so important to explore ‘how’ clinical research can work with community hospitals,” said Madeline Sparks Cresswell, MBA, Research Program Manager – OHSU Health, Clinical Research Services Office (CRSO), Oregon Health & Science University.

Key topics for 2023 include:

  • The business case for CRAACO
  • Patients first
  • Democratizing access and connecting the ecosystem
  • Community integration
  • Workforce issues in clinical research
  • Integrating digital innovation
  • EHRs & data from care to research

To learn more about the event and to read the full agenda, please visit craacoevent.com.

About CRAACO®: Clinical Research as a Care Option

The Clinical Research as a Care Option event (CRAACO) is the first conference dedicated to bringing together health systems, pharma, patients, regulators and innovators to address the value, challenges and success stories of integrating clinical research options in the clinical care space for the benefit of patients.

About the Conference Forum

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.

They currently offer conferences for pharma/biotech professionals including R&D leaders, CEOs, business development/licensing, medical affairs/safety, chief patient officers/advocates, clinical innovation champions, investors and drug delivery specialists. The company also publishes six newsletters and produces PharmaTalkRadio and virtual events.

Share article on social media or email:

InterExchange Awards Exclusive Fellowship to Support Social, Environmental and Humanitarian Impact


Postpandemic, we see that the need for altruistic service projects in line with UN Sustainable Development Goals is more important than ever. We look forward to doing our part so that our Fellows can do theirs.

InterExchange is proud to announce that it will be awarding up to $100,000 in fellowships in 2023 to support sustainable international volunteer projects. The Christianson Fellowship—which provides funding up to $10,000 per recipient—will be awarded to individuals working on projects that align with the InterExchange mission, and will provide recipients with the resources and support they need to make a sustainable, positive impact in communities around the world. Since its inception in 2007, the Christianson Fellowship has supported more than 100 individuals carrying out volunteer projects abroad of varying lengths (minimum six months requirement) in all corners of the globe.

“The InterExchange Christianson Fellowship is a truly unique source of funding support for inspiring young Americans committed to doing good in the world,” says Christine La Monica-Lunn, President & CEO of InterExchange. “Since the beginning of our commitment to meaningful philanthropic activity, we have made it a priority to consider a wide range of impactful projects around the world in line with the motivations and future career goals of our exceptional Fellows. Postpandemic, we see that the need for altruistic service projects in line with UN Sustainable Development Goals is more important than ever. We look forward to doing our part so that our Fellows can do theirs.”

The Christianson Fellowship is open to applicants from a wide range of backgrounds and experiences. Christianson Fellows have had a lasting, positive impact on rural and urban communities in 42 countries across five continents, engaging in meaningful service projects in a broad array of fields. Most recently, InterExchange has provided support to inspired young Americans involved in restorative justice, sports diplomacy, and clean water projects in South Africa, Panama, and India. Alumni have gone on to pursue careers as medical doctors and researchers, civil servants, entrepreneurs, and even as founders of their own NGOs, both in the United States and abroad.

“The Christianson Fellowship for me was the foundation to who I am today,” says Sheila Xu, a 2015 Christianson Fellow whose project focused on organizing resources for the deaf community in Italy’s Veneto Province. “Once I looked at the Christianson Fellowship I thought it was a perfect match because I could create what I wanted… and that, truly, started off my entire journey to lead me to where I am now.”

Applications are accepted on a rolling basis and will be reviewed after the close of each application deadline (March 15, July 15, October 15). For more information about the Fellowship and application process, please visit https://www.interexchange.org/foundation.

About InterExchange: InterExchange is a private, nonprofit organization with 55 years of experience in international cultural exchange. We are dedicated to promoting international understanding through development and implementation of affordable intercultural and life experiential work/training opportunities. Our mission is to promote cultural awareness, knowledge, and global competence among people from around the world through international exchange programs, offering work and training opportunities in the United States and abroad.

Share article on social media or email:

Origins Counseling Center in Dallas Launches Mental Health Intensive Outpatient Program


Stigma around mental health concerns prevents many individuals from seeking the help they need. Like any health concern, mental health can improve with treatment.

Origins Counseling Center in Dallas, Texas, will open its new Mental Health Intensive Outpatient Program (IOP) on March 6, 2023. This valuable new program will meet the critical need for outpatient services for individuals with mental health disorders. Clinical Director Shea Barakatt, MA, LCSW, LCDC, understands mental health’s impact on adults and their family systems.

“Mental health is just as important as physical health. If one of these elements is ignored, it can affect the whole person. Beyond that, untreated mental health symptoms can dramatically impact a person’s social relationships, job or academic performance, and family system,” says Barakatt. “By acknowledging and addressing mental health concerns, people from all walks of life can learn valuable tools to help them find improved self-esteem and reach their highest potential.”

The new Mental Health IOP framework at Origins Counseling Center in Dallas offers a sophisticated in-network treatment option for individuals with mental health concerns who want to amplify their healing process. While individual therapy can be a powerful resource, coupling this with intensive group therapies can help people with mental health disorders develop a network of lasting, peer-driven support. Mental Health IOP is a good option for those who are psychiatrically stable or recently discharged from a residential psychiatric treatment program and want the continued support and motivation provided by group therapy sessions.

Origins’ compassionate therapists and counselors help identify and treat a wide range of mental health disorders, including depression, borderline personality disorder (BPD), anxiety, mood disorders, bipolar disorders, trauma and post-traumatic stress disorders (PTSD), adjustment disorders, grief and loss, obsessive-compulsive disorders, process addictions, and more. These masters-level clinicians leverage evidence-based modalities such as Dialectical Behavior Therapy (DBT), Cognitive Behavior Therapy (CBT), psychoeducation, biofeedback, Eye-Movement Desensitization and Reprocessing (EMDR), and expressive arts therapy.

Patients are surrounded three days a week by an empathetic group of clinical professionals. Therapists help patients learn coping mechanisms and practical strategies to use when they feel overwhelmed to help improve their quality of life. Origins’ Mental Health IOP offers a chance to gain emotional stability in a safe, supportive environment while carefully monitoring patients’ progress. The program accepts insurance and is in-network with Blue Cross and Blue Shield of Texas.

“Stigma around mental health concerns prevents many individuals from seeking the help they need. Like any health concern, mental health can improve with treatment,” says Barakatt. “We want our patients to know that there is hope and that healing is possible for them. We are honored to be able to expand our services to this realm and, in the process, help to lessen the stigma surrounding mental health.”

Patients in the Mental Health IOP will learn vital coping skills to help navigate work-related stress and burnout, the challenges of parental, family, and social relationships, financial pressures, grief and loss, and other medical diagnoses and health concerns. The goal is for individuals to gain a newfound sense of self-worth, direction, and control that they can bring into every aspect of their lives.

Call Origins Counseling Center’s Mental Health IOP at 855.741.4673 or fill out our online contact form: originscounselingdallas.com/contact-us/.

About Origins Behavioral HealthCare

Origins Behavioral HealthCare offers a range of treatment programs targeting recovery from substance use, mental health issues, and beyond. Our primary mission is to provide a clear path to a life of healing and restoration. We offer renowned clinical care for addiction and mental health concerns and have the compassion and professional expertise to guide you toward healing. Visit OriginsRecovery.com or call 855.741.4673.

About Origins Counseling Center in Dallas

Origins Counseling Center, based in Dallas, Texas, offers outpatient addiction and mental health treatment for men, women, and families. We serve everyone—from business professionals and stay-at-home moms to young college students. With compassion and expertise, our gifted therapists can empower you with the tools you need to embrace a whole, healthy life. Our team uses evidence-based therapies and interventions for substance use, mental health, and co-occurring disorders, and we develop personalized treatment plans for each patient. Visit OriginsCounselingDallas.com or call 855.741.4673.

Share article on social media or email: